

HY-172808 · 50 mg
MedChemExpress · Cat: HY-172808
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bns808.html
Description
BNS808 is an orally active and selective cannabinoid-1 receptor CB1R antagonist IC50 = 0.8 nM with notable CB2R selectivity and minimal brain penetration. BNS808 is studied in research on obesity and its associated metabolic complications, such as metabolic dysfunctional-associated steatotic liver disease MASLD . BNS808 has reduced free drug availability for CNS entry, enhancing safety and minimizing drug-drug interactions through high plasma binding.







